By Donato Paolo Mancini 
 

Fresenius Medical Care AG & Co. KGaA (FME.XE) and NxStage Medical Inc. (NXTM) have extended their merger agreement end date due to the U.S. government shutdown, Fresenius said Tuesday.

The move is to account for the interruption of the Federal Trade Commission's review of the transaction during the recent shutdown.

The merger date has been moved to Aug. 6, 2019, or to an earlier date for which the FTC will have been fully funded for 60 consecutive days, Germany's Fresenius said.

 

Write to Donato Paolo Mancini at donatopaolo.mancini@dowjones.com; @donatopmancini

 

(END) Dow Jones Newswires

January 29, 2019 08:31 ET (13:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Nxstage Medical Charts.
Nxstage Medical (NASDAQ:NXTM)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Nxstage Medical Charts.